Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy
Qiying Zhang,1 Jing Zhang,1 Zi Liu,1,2 Juan Wang,1 Fei Wang,1 Tao Wang,1 Fan Shi,1 Jin Su,1 Yalong Zhao3 1Department of Radiation Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, People's Republic of China; 2Biobank, the First Affiliated Hospital of...
Saved in:
Main Authors: | Zhang Q (Author), Zhang J (Author), Liu Z (Author), Wang J (Author), Wang F (Author), Wang T (Author), Shi F (Author), Su J (Author), Zhao Y (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cervical cancer: Part II the landscape of treatment for persistent, recurrent and metastatic diseases (I)
by: Szu-Ting Yang, et al.
Published: (2024) -
Prognostic impact of adding bevacizumab to carboplatin and paclitaxel for recurrent, persistent, or metastatic cervical cancer
by: Masafumi Yasunaga, et al.
Published: (2022) -
Dendritic cells transduced with TIPE-2 recombinant adenovirus induces T cells suppression
by: Shudong Liu, et al.
Published: (2021) -
The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study
by: Yu J, et al.
Published: (2019) -
Sex-specific recombination patterns predict parent of origin for recurrent genomic disorders
by: Trenell J. Mosley, et al.
Published: (2021)